Functional-three-dimensional Reconstruction of Liver by 99MTc-GSA-SPECT Scan

The recruitment status of this study is unknown because the information has not been verified recently.

Verified May 2011 by Peking Union Medical College Hospital.
Recruitment status was Recruiting

Sponsor:

Information provided by:

Peking Union Medical College Hospital

ClinicalTrials.gov Identifier:

NCT01350726

First received: May 8, 2011

Last updated: May 9, 2011

Last verified: May 2011

History of Changes

Purpose

The aims of this study were divided into three parts:

To develop a new software to carry out the functional-three- dimensional-reconstruction of the liver by 99mTc-GSA-SPECT scintigraphy
To probe a new dynamic model of the metabolism of the 99mTc-GSA.
To evaluate the liver function by 99mTc-GSA-SPECT scintigraphy before surgical treatment.

Study design:

Collectivity type: Prospective，randomized, controlled, multi-central clinical study.
Patients: The subjects were from different hospitals including: Peking Union Medical College Hospital (PUMCH).

Study arrangement:

This study was consisted of three parts:

Condition
Cirrhosis Hepatic Carcinoma

Study Type:	Observational
Study Design:	Observational Model: Case Control Time Perspective: Prospective
Official Title:	Functional-three-dimensional Reconstruction and Functional Evaluation of Liver by 99MTc-GSA-SPECT Scintigraphy

Resource links provided by NLM:

Genetics Home Reference related topics: North American Indian childhood cirrhosis

MedlinePlus related topics: Cirrhosis Nuclear Scans Plastic and Cosmetic Surgery

U.S. FDA Resources

Further study details as provided by Peking Union Medical College Hospital:

Estimated Enrollment:	0
Study Start Date:	January 2008
Estimated Study Completion Date:	July 2011
Primary Completion Date:	May 2011 (Final data collection date for primary outcome measure)

Groups/Cohorts
Normal control Subjects without liver cirrhosis and normal volunteers.
Cirrhosis group Subjects with liver cirrhosis.

Eligibility

Ages Eligible for Study:	18 Years to 85 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes
Sampling Method:	Probability Sample

Study Population

The subjects were from Peking Union Medical College Hospital from May, 2008 to the end of the study.

Criteria

Inclusion Criteria:

Patients that with benign tumor、hepatitis and hepatic carcinoma (with or without cirrhosis)diagnosed by examination of CT, ultrasound-B, and/or pathology.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT01350726

Locations

China, Beijing
Peking Union Medical College Hospital	Recruiting
Beijing, Beijing, China, 100730
Contact: Yilei Mao, M. D, Ph. D +86-10-65296042 pumch.liver@hotmail.com
Principal Investigator: Yilei Mao, M. D, Ph. D

Sponsors and Collaborators

Peking Union Medical College Hospital

More Information

No publications provided

Responsible Party:	Dr. Yilei Mao, Peking Union Medical College Hospital
ClinicalTrials.gov Identifier:	NCT01350726 History of Changes
Other Study ID Numbers:	PUMCH-Liver surgery -GSA
Study First Received:	May 8, 2011
Last Updated:	May 9, 2011
Health Authority:	China: Ethics Committee

Keywords provided by Peking Union Medical College Hospital:

Cirrhosis
Hepatic Carcinoma

Additional relevant MeSH terms:

Carcinoma
Liver Cirrhosis
Fibrosis
Carcinoma, Hepatocellular
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms

Liver Diseases
Digestive System Diseases
Pathologic Processes
Adenocarcinoma
Liver Neoplasms
Digestive System Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on June 18, 2013

To Top